Gokaldas Exports Logs 9 Sequential Revenue Increase in Q4 Driven by Operational Efficiencies Indian Commerce Minister Piyush Goyal to Lead 150Member Business Delegation to Canada to Strengthen Trade Ties EU Fines Temu 200 Million for Failing to Curb Sale of Illegal and Unsafe Products IRS Settlement Blocks Tax Audits on Trump and Family Businesses Irans Strait of Hormuz Threat Sparks Oil Market Jitters Analysts Warn of Supply Risks UltraRich in Germany Control Over 25 of Financial Wealth BCG Report Reveals FBNC Q1 2026 Earnings Slight EPS Beat Amid Stable Performance GLPI Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Unreported Lightspeed Commerce Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction HTLD Q1 2026 Earnings NarrowerThanExpected Loss Surprises Markets Bolt Biotherapeutics Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Stage Brookfield Infrastructure Partners LP Q1 2026 Earnings Steep EPS Miss Pressures Stock BRC Group Holdings Notes Edge Higher Amid Mixed FixedIncome Sentiment Cal Redwood Acquisition Corp Right CRAQR Holds Steady Near Support as SPAC Rights Trade Flat CarPartscom PRTS Holds Steady Near Support Level After Modest Gain CUBB Holds Steady Near Key Levels Amid Minimal Price Movement Neuberger Energy Infrastructure Fund NML Pulls Back Testing Key Support Levels Meta May Enter Cloud Computing Market Zuckerberg Suggests MRTN Q1 2026 Earnings EPS Beats Estimates by 1765 Shares Edge Higher International Flavors Fragrances IFF Holds Near 75 as Flat Session Suggests Consolidation PDS Biotechnology Q1 2026 Earnings EPS Beat Highlights Progress Despite PreRevenue Status NKE Q1 2026 Earnings Strong EPS Beat Amidst Uncertain Revenue Landscape APTV Q1 2026 Earnings EPS Beats Estimates Amid Solid Operational Performance Daily Journal Corp Q4 2025 Earnings Strong EPS of 3061 Reported Amid Flat Stock Reaction CHE Q1 2026 Earnings EPS Beats Estimates by 55 ONE Gas Inc OGS Q1 2026 Earnings EPS Misses Estimates Yet Shares Edge Higher ESLA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as ClinicalStage Biotech Continues RD Spending